Emergence of Human Immunodeficiency Virus-1 Drug Resistance During the 3-Month World Health Organization-Recommended Enhanced Adherence Counseling Period in the CART-1 Cohort Study.

Jennifer Anne Brown Herbert A Mbunkah Thabo Ishmael LejoneIsaac RingeraMolisana CheleboiThomas Klimkait Karin J Metzner Huldrych F Gunthard Niklaus Daniel Labhardt Roger D Kouyos Nadine Tschumi

Published in: Open forum infectious diseases (2021)

Despite high levels of resistance before EAC, we observed a slight decline in susceptibility scores after EAC. The risk of further accumulation of resistance during EAC has to be balanced against the benefit of avoiding unnecessary switches in those with spontaneous resuppression after EAC.

Keyphrases

human immunodeficiency virus
hepatitis c virus
antiretroviral therapy
hiv infected
hiv positive
hiv aids
hiv testing
type diabetes
adipose tissue